Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seroquel XR in pediatric bipolar depression
NCT00811473Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2009
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 7
01
Overview
Phase 3, randomised, double-blind trial in bipolar disorder (BD) comparing Quetiapine XR with Placebo (2 arms). Primary endpoint: Children's Depression Rating Scale-Revised Total Score at Day 57. Started Jan 2009; status: completed.
02
Drugs
quetiapine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00811473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00811473.